{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T01:21:47Z","timestamp":1772760107770,"version":"3.50.1"},"reference-count":96,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"17","license":[{"start":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T00:00:00Z","timestamp":1745539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007834","name":"Ningbo Natural Science Foundation","doi-asserted-by":"crossref","award":["2023J316"],"award-info":[{"award-number":["2023J316"]}],"id":[{"id":"10.13039\/100007834","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Medical Scientific Research Foundation of Zhejiang Province","award":["2022KY1138"],"award-info":[{"award-number":["2022KY1138"]}]},{"name":"HwaMei Reasearch Foundation of Ningbo No.2 Hospital","award":["2023HMKY20"],"award-info":[{"award-number":["2023HMKY20"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,4,25]]},"abstract":"<jats:p>Malignant mesothelioma (MM) is a rare but aggressive cancer originating from mesothelial cells, which presents significant challenges to patients\u2019 physical and psychological well-being. The gut\u2013lung axis underscores the connection between gut microbiota and respiratory diseases, with emerging evidence suggesting a strong association between gut microbiota and the development of MM. In this study, we conducted a two-sample Mendelian randomization (MR) analysis to investigate the potential causal relationship between gut microbiota and MM, while also exploring the underlying mechanisms through bioinformatics approaches. Gut microbiota summary data were obtained from the MiBioGen consortium, while MM data were sourced from the FinnGen R11 dataset. Causality was examined using the inverse variance weighted method as the primary analysis. Additional methods, including the weighted median, simple mode, MR-Egger, and weighted mode, were also employed. The robustness of the findings was validated through sensitivity analyses, and reverse causality was considered to further strengthen the MR results. Moreover, bioinformatics analyses were conducted on genetic loci associated with both gut microbiota and MM to explore potential underlying mechanisms. Our study suggests that genetically predicted increases in <jats:italic toggle=\"yes\">class.Bacilli<\/jats:italic>, <jats:italic toggle=\"yes\">family.Rikenellaceae<\/jats:italic>, <jats:italic toggle=\"yes\">genus.Clostridium innocuum group<\/jats:italic>, and <jats:italic toggle=\"yes\">order.Lactobacillales<\/jats:italic> were suggestively associated with a higher risk of MM, whereas increases in <jats:italic toggle=\"yes\">genus.Ruminococcaceae UCG004<\/jats:italic>, <jats:italic toggle=\"yes\">genus.Flavonifractor<\/jats:italic>, <jats:italic toggle=\"yes\">phylum.Firmicutes<\/jats:italic>, <jats:italic toggle=\"yes\">genus.Anaerofilum<\/jats:italic>, <jats:italic toggle=\"yes\">genus.Clostridium sensu stricto 1<\/jats:italic>, and <jats:italic toggle=\"yes\">genus.Lactobacillus<\/jats:italic> appeared to confer protective effects. Bioinformatics analysis indicated that differentially expressed genes near loci associated with gut microbiota might affect MM by modulating pathways and the tumor microenvironment. The results of this study point to a potential genetic predisposition linking gut microbiota to MM. Further experimental validation is crucial to confirm these candidate microbes, establish causality, and elucidate the underlying mechanisms.<\/jats:p>","DOI":"10.1097\/md.0000000000042245","type":"journal-article","created":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T23:01:24Z","timestamp":1745881284000},"page":"e42245","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["Bidirectional Mendelian randomization and potential mechanistic insights into the causal relationship between gut microbiota and malignant mesothelioma"],"prefix":"10.1097","volume":"104","author":[{"given":"Yinjie","family":"Zhou","sequence":"first","affiliation":[{"name":"Department of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huangkai","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Long","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guofang","family":"Zhao","sequence":"additional","affiliation":[{"name":"Department of Thoracic Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4904-5405","authenticated-orcid":false,"given":"Jiaen","family":"Sun","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Surgery, Ningbo No. 2 Hospital, Ningbo, Zhejiang, China."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20250904","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1097\/JTO.0000000000000471","article-title":"High incidence of somatic BAP1 alterations in sporadic malignant mesothelioma.","volume":"10","author":"Nasu","year":"2015","journal-title":"J Thorac Oncol"},{"key":"R2-20250904","doi-asserted-by":"crossref","first-page":"2782590","DOI":"10.1155\/2017\/2782590","article-title":"Life expectancy in pleural and peritoneal mesothelioma.","volume":"2017","author":"Shavelle","year":"2017","journal-title":"Lung Cancer Int"},{"key":"R3-20250904","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s13046-022-02455-6","article-title":"Artichoke phytocomplex modulates serum microRNAs in patients exposed to asbestos: a first step of a phase II clinical trial.","volume":"41","author":"Muti","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"R4-20250904","first-page":"402","article-title":"Mesothelioma: scientific clues for prevention, diagnosis, and therapy.","volume":"69","author":"Carbone","year":"2019","journal-title":"CA Cancer J Clin"},{"key":"R5-20250904","doi-asserted-by":"crossref","first-page":"e13631","DOI":"10.15252\/emmm.202013631","article-title":"KRAS signaling in malignant pleural mesothelioma.","volume":"14","author":"Marazioti","year":"2022","journal-title":"EMBO Mol Med"},{"key":"R6-20250904","doi-asserted-by":"crossref","first-page":"584","DOI":"10.21037\/tlcr.2018.07.06","article-title":"Is there a role for prophylactic radiotherapy to intervention tract sites in patients with malignant pleural mesothelioma?","volume":"7","author":"Halford","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"R7-20250904","doi-asserted-by":"crossref","first-page":"809337","DOI":"10.3389\/fphar.2021.809337","article-title":"A glimpse in the future of malignant mesothelioma treatment.","volume":"12","author":"Pezzicoli","year":"2021","journal-title":"Front Pharmacol"},{"key":"R8-20250904","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13046-022-02284-7","article-title":"SKP2 drives the sensitivity to neddylation inhibitors and cisplatin in malignant pleural mesothelioma.","volume":"41","author":"Salaroglio","year":"2022","journal-title":"J Exp Clin Cancer Res"},{"key":"R9-20250904","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1002\/cncr.33433","article-title":"Malignant mesothelioma: advances in immune checkpoint inhibitor and mesothelin-targeted therapies.","volume":"127","author":"Hu","year":"2021","journal-title":"Cancer"},{"key":"R10-20250904","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing.","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"R11-20250904","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00018-018-2943-4","article-title":"An insight into gut microbiota and its functionalities.","volume":"76","author":"Adak","year":"2019","journal-title":"Cell Mol Life Sci"},{"key":"R12-20250904","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression.","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov"},{"key":"R13-20250904","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1126\/science.aan3706","article-title":"Gut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors.","volume":"359","author":"Routy","year":"2018","journal-title":"Science"},{"key":"R14-20250904","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1631\/jzus.B2000602","article-title":"Screening beneficial bacteriostatic lactic acid bacteria in the intestine and studies of bacteriostatic substances.","volume":"22","author":"Liu","year":"2021","journal-title":"J Zhejiang Univ Sci B"},{"key":"R15-20250904","doi-asserted-by":"crossref","first-page":"1129513","DOI":"10.3389\/fimmu.2023.1129513","article-title":"Intratumor microbiota as a novel potential prognostic indicator in mesothelioma.","volume":"14","author":"Pentimalli","year":"2023","journal-title":"Front Immunol"},{"key":"R16-20250904","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.xjon.2024.02.007","article-title":"Use of a novel microbiome modulator improves anticancer immunity in a murine model of malignant pleural mesothelioma.","volume":"18","author":"Gattlen","year":"2024","journal-title":"JTCVS Open"},{"key":"R17-20250904","doi-asserted-by":"crossref","first-page":"7187","DOI":"10.1038\/s41467-024-49842-5","article-title":"A gut microbiota rheostat forecasts responsiveness to PD-L1 and VEGF blockade in mesothelioma.","volume":"15","author":"Zhang","year":"2024","journal-title":"Nat Commun"},{"key":"R18-20250904","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/jrsm.1346","article-title":"Meta-analysis and mendelian randomization: a review.","volume":"10","author":"Bowden","year":"2019","journal-title":"Res Synth Methods"},{"key":"R19-20250904","doi-asserted-by":"crossref","first-page":"R89","DOI":"10.1093\/hmg\/ddu328","article-title":"Mendelian randomization: genetic anchors for causal inference in epidemiological studies.","volume":"23","author":"Davey Smith","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R20-20250904","doi-asserted-by":"crossref","first-page":"3253","DOI":"10.1681\/ASN.2016010098","article-title":"Mendelian randomization as an approach to assess causality using observational data.","volume":"27","author":"Sekula","year":"2016","journal-title":"J Am Soc Nephrol"},{"key":"R21-20250904","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1038\/s41588-020-00763-1","article-title":"Large-scale association analyses identify host factors influencing human gut microbiome composition.","volume":"53","author":"Kurilshikov","year":"2021","journal-title":"Nat Genet"},{"key":"R22-20250904","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/ije\/dyr036","article-title":"Avoiding bias from weak instruments in Mendelian randomization studies.","volume":"40","author":"Burgess","year":"2011","journal-title":"Int J Epidemiol"},{"key":"R23-20250904","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1158\/0008-5472.CAN-20-0985","article-title":"LDtrait: an online tool for identifying published phenotype associations in linkage disequilibrium.","volume":"80","author":"Lin","year":"2020","journal-title":"Cancer Res"},{"key":"R24-20250904","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/s10654-017-0255-x","article-title":"Interpreting findings from Mendelian randomization using the MR-Egger method.","volume":"32","author":"Burgess","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"R25-20250904","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1097\/EDE.0000000000000559","article-title":"Sensitivity analyses for robust causal inference from mendelian randomization analyses with multiple genetic variants.","volume":"28","author":"Burgess","year":"2017","journal-title":"Epidemiology"},{"key":"R26-20250904","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/ije\/dyy101","article-title":"Improving the visualization, interpretation and analysis of two-sample summary data Mendelian randomization via the Radial plot and Radial regression.","volume":"47","author":"Bowden","year":"2018","journal-title":"Int J Epidemiol"},{"key":"R27-20250904","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1038\/s41588-018-0099-7","article-title":"Detection of widespread horizontal pleiotropy in causal relationships inferred from Mendelian randomization between complex traits and diseases.","volume":"50","author":"Verbanck","year":"2018","journal-title":"Nat Genet"},{"key":"R28-20250904","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat Commun"},{"key":"R29-20250904","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s40364-021-00264-1","article-title":"Anti-Mesothelin CAR T cell therapy for malignant mesothelioma.","volume":"9","author":"Castelletti","year":"2021","journal-title":"Biomark Res"},{"key":"R30-20250904","doi-asserted-by":"crossref","first-page":"118123","DOI":"10.1016\/j.lfs.2020.118123","article-title":"New vistas in malignant mesothelioma: microRNA architecture and NRF2\/MAPK signal transduction.","volume":"257","author":"Gandhi","year":"2020","journal-title":"Life Sci"},{"key":"R31-20250904","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease.","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"R32-20250904","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.ccell.2021.08.006","article-title":"Microbiome and cancer.","volume":"39","author":"Cullin","year":"2021","journal-title":"Cancer Cell"},{"key":"R33-20250904","doi-asserted-by":"crossref","first-page":"1139821","DOI":"10.3389\/fimmu.2023.1139821","article-title":"Emerging roles of the gut microbiota in cancer immunotherapy.","volume":"14","author":"Shi","year":"2023","journal-title":"Front Immunol"},{"key":"R34-20250904","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrmicro.2016.142","article-title":"Emerging pathogenic links between microbiota and the gut\u2013lung axis.","volume":"15","author":"Budden","year":"2017","journal-title":"Nat Rev Microbiol"},{"key":"R35-20250904","doi-asserted-by":"crossref","first-page":"e12356","DOI":"10.1002\/clt2.12356","article-title":"Gut-lung axis and asthma: a historical review on mechanism and future perspective.","volume":"14","author":"Song","year":"2024","journal-title":"Clin Transl Allergy"},{"key":"R36-20250904","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fmicb.2018.00151","article-title":"Gut microbiota: an integral moderator in health and disease.","volume":"9","author":"Feng","year":"2018","journal-title":"Front Microbiol"},{"key":"R37-20250904","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3390\/microorganisms9010189","article-title":"microbiome signatures in a fast- and slow-progressing gastric cancer murine model and their contribution to gastric carcinogenesis.","volume":"9","author":"Bali","year":"2021","journal-title":"Microorganisms"},{"key":"R38-20250904","doi-asserted-by":"crossref","first-page":"1296417","DOI":"10.3389\/fcimb.2023.1296417","article-title":"The relationship between gut microbiota and insomnia: a bi-directional two-sample Mendelian randomization research.","volume":"13","author":"Li","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R39-20250904","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1002\/cncr.34951","article-title":"Association of habitual sleep duration and its trajectory with the risk of cancer according to sex and body mass index in a population-based cohort.","volume":"129","author":"Ning","year":"2023","journal-title":"Cancer"},{"key":"R40-20250904","doi-asserted-by":"crossref","first-page":"444","DOI":"10.18632\/oncotarget.13443","article-title":"Evolutionary biologic changes of gut microbiota in an \u2018adenoma-carcinoma sequence\u2019 mouse colorectal cancer model induced by 1, 2-Dimethylhydrazine.","volume":"8","author":"Sun","year":"2017","journal-title":"Oncotarget"},{"key":"R41-20250904","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s40364-024-00607-8","article-title":"Gut microbiota and metabolites signatures of clinical response in anti-PD-1\/PD-L1 based immunotherapy of biliary tract cancer.","volume":"12","author":"Zhu","year":"2024","journal-title":"Biomark Res"},{"key":"R42-20250904","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1186\/s12967-022-03481-w","article-title":"The treatment of Qibai Pingfei Capsule on chronic obstructive pulmonary disease may be mediated by Th17\/Treg balance and gut\u2013lung axis microbiota.","volume":"20","author":"Jia","year":"2022","journal-title":"J Transl Med"},{"key":"R43-20250904","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.atherosclerosis.2018.02.036","article-title":"The gut microbiome and elevated cardiovascular risk in obesity and autoimmunity.","volume":"271","author":"Kasselman","year":"2018","journal-title":"Atherosclerosis"},{"key":"R44-20250904","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.celrep.2018.08.078","article-title":"Consumption of mediterranean versus western diet leads to distinct mammary gland microbiome populations.","volume":"25","author":"Shively","year":"2018","journal-title":"Cell Rep"},{"key":"R45-20250904","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s40001-024-01741-7","article-title":"Univariable and multivariable Mendelian randomization study identified the key role of gut microbiota in immunotherapeutic toxicity.","volume":"29","author":"Liu","year":"2024","journal-title":"Eur J Med Res"},{"key":"R46-20250904","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1186\/s12885-024-12205-w","article-title":"Investigating the causal role of the gut microbiota in esophageal cancer and its subtypes: a two-sample Mendelian randomization study.","volume":"24","author":"Li","year":"2024","journal-title":"BMC Cancer"},{"key":"R47-20250904","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.biocel.2008.06.014","article-title":"Teneurins: important regulators of neural circuitry.","volume":"41","author":"Young","year":"2009","journal-title":"Int J Biochem Cell Biol"},{"key":"R48-20250904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.canlet.2012.07.021","article-title":"Teneurin protein family: an emerging role in human tumorigenesis and drug resistance.","volume":"326","author":"Ziegler","year":"2012","journal-title":"Cancer Lett"},{"key":"R49-20250904","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/annonc\/mdy011","article-title":"A mutational signature associated with alcohol consumption and prognostically significantly mutated driver genes in esophageal squamous cell carcinoma.","volume":"29","author":"Li","year":"2018","journal-title":"Ann Oncol"},{"key":"R50-20250904","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1101\/gad.873001","article-title":"A mutation in a mitochondrial transmembrane protein is responsible for the pleiotropic hematological and skeletal phenotype of flexed-tail (f\/f) mice.","volume":"15","author":"Fleming","year":"2001","journal-title":"Genes Dev"},{"key":"R51-20250904","doi-asserted-by":"crossref","first-page":"107449","DOI":"10.1016\/j.lungcan.2023.107449","article-title":"SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with (18)F-FDG metabolic parameters.","volume":"188","author":"Zhang","year":"2024","journal-title":"Lung Cancer"},{"key":"R52-20250904","doi-asserted-by":"crossref","first-page":"111918","DOI":"10.1016\/j.intimp.2024.111918","article-title":"SFXN1-mediated immune cell infiltration and tumorigenesis in lung adenocarcinoma: a potential therapeutic target.","volume":"132","author":"Li","year":"2024","journal-title":"Int Immunopharmacol"},{"key":"R53-20250904","doi-asserted-by":"crossref","first-page":"217008","DOI":"10.1016\/j.canlet.2024.217008","article-title":"Sideroflexin-1 promotes progression and sensitivity to lapatinib in triple-negative breast cancer by inhibiting TOLLIP-mediated autophagic degradation of CIP2A.","volume":"597","author":"Andriani","year":"2024","journal-title":"Cancer Lett"},{"key":"R54-20250904","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1083\/jcb.200511061","article-title":"KIF14 and citron kinase act together to promote efficient cytokinesis.","volume":"172","author":"Gruneberg","year":"2006","journal-title":"J Cell Biol"},{"key":"R55-20250904","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1038\/labinvest.2017.48","article-title":"The kinesin KIF14 is overexpressed in medulloblastoma and downregulation of KIF14 suppressed tumor proliferation and induced apoptosis.","volume":"97","author":"Li","year":"2017","journal-title":"Lab Invest"},{"key":"R56-20250904","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1002\/ijc.26189","article-title":"Kinesin family member 14: an independent prognostic marker and potential therapeutic target for ovarian cancer.","volume":"130","author":"Theriault","year":"2012","journal-title":"Int J Cancer"},{"key":"R57-20250904","first-page":"239","article-title":"High expression of KIF14 is associated with poor prognosis in patients with epithelial ovarian cancer.","volume":"21","author":"Qiu","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"R58-20250904","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1038\/emm.2014.23","article-title":"Silencing of KIF14 interferes with cell cycle progression and cytokinesis by blocking the p27(Kip1) ubiquitination pathway in hepatocellular carcinoma.","volume":"46","author":"Xu","year":"2014","journal-title":"Exp Mol Med"},{"key":"R59-20250904","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s12935-022-02610-1","article-title":"Comprehensive analyses reveal the carcinogenic and immunological roles of ANLN in human cancers.","volume":"22","author":"Shi","year":"2022","journal-title":"Cancer Cell Int"},{"key":"R60-20250904","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.hbpd.2020.08.007","article-title":"Overexpression of anillin is related to poor prognosis in patients with hepatocellular carcinoma.","volume":"20","author":"Zhang","year":"2021","journal-title":"Hepatobiliary Pancreat Dis Int"},{"key":"R61-20250904","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1038\/s41598-017-02990-9","article-title":"Transcriptome sequencing identifies ANLN as a promising prognostic biomarker in bladder urothelial carcinoma.","volume":"7","author":"Zeng","year":"2017","journal-title":"Sci Rep"},{"key":"R62-20250904","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2184.2003.00266.x","article-title":"The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.","volume":"36","author":"Vermeulen","year":"2003","journal-title":"Cell Prolif"},{"key":"R63-20250904","doi-asserted-by":"crossref","first-page":"e31586","DOI":"10.1016\/j.heliyon.2024.e31586","article-title":"High expression of CCNB2 is an independent predictive poor prognostic biomarker and correlates with immune infiltrates in breast carcinoma.","volume":"10","author":"Lu","year":"2024","journal-title":"Heliyon"},{"key":"R64-20250904","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.biopha.2015.08.004","article-title":"CCNB2 overexpression is a poor prognostic biomarker in Chinese NSCLC patients.","volume":"74","author":"Qian","year":"2015","journal-title":"Biomed Pharmacother"},{"key":"R65-20250904","first-page":"208","article-title":"Roles of CCNB2 and NKX3-1 in nasopharyngeal carcinoma.","volume":"35","author":"Qian","year":"2020","journal-title":"Cancer Biother Radiopharm"},{"key":"R66-20250904","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1038\/sj.onc.1205257","article-title":"Overexpression of B-type cyclins alters chromosomal segregation.","volume":"21","author":"Sarafan-Vasseur","year":"2002","journal-title":"Oncogene"},{"key":"R67-20250904","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1172\/JCI95148","article-title":"Mechanisms and functions of cellular senescence.","volume":"128","author":"Herranz","year":"2018","journal-title":"J Clin Invest"},{"key":"R68-20250904","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","article-title":"The senescence-associated secretory phenotype: the dark side of tumor suppression.","volume":"5","author":"Coppe","year":"2010","journal-title":"Annu Rev Pathol"},{"key":"R69-20250904","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s10555-010-9220-9","article-title":"Senescent cells as a source of inflammatory factors for tumor progression.","volume":"29","author":"Davalos","year":"2010","journal-title":"Cancer Metastasis Rev"},{"key":"R70-20250904","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","article-title":"Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor.","volume":"6","author":"Coppe","year":"2008","journal-title":"PLoS Biol"},{"key":"R71-20250904","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12307-011-0069-4","article-title":"Epithelial-mesenchymal transition induced by senescent fibroblasts.","volume":"5","author":"Laberge","year":"2012","journal-title":"Cancer Microenviron"},{"key":"R72-20250904","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1161\/01.RES.0000159708.71142.c8","article-title":"Syndecans: new kids on the signaling block.","volume":"96","author":"Tkachenko","year":"2005","journal-title":"Circ Res"},{"key":"R73-20250904","doi-asserted-by":"crossref","first-page":"6245","DOI":"10.1158\/0008-5472.CAN-04-4244","article-title":"Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling.","volume":"65","author":"Capurro","year":"2005","journal-title":"Cancer Res"},{"key":"R74-20250904","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/j.1582-4934.2010.01236.x","article-title":"Proteoglycans in cancer biology, tumour microenvironment and angiogenesis.","volume":"15","author":"Iozzo","year":"2011","journal-title":"J Cell Mol Med"},{"key":"R75-20250904","doi-asserted-by":"crossref","first-page":"90","DOI":"10.20892\/j.issn.2095-3941.2016.0086","article-title":"Roles of Rap1 signaling in tumor cell migration and invasion.","volume":"14","author":"Zhang","year":"2017","journal-title":"Cancer Biol Med"},{"key":"R76-20250904","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/nature12626","article-title":"Influence of tumour micro-environment heterogeneity on therapeutic response.","volume":"501","author":"Junttila","year":"2013","journal-title":"Nature"},{"key":"R77-20250904","doi-asserted-by":"crossref","first-page":"3563","DOI":"10.3390\/ijms25063563","article-title":"Immunotherapy and cancer: the multi-omics perspective.","volume":"25","author":"Donisi","year":"2024","journal-title":"Int J Mol Sci"},{"key":"R78-20250904","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1146\/annurev-immunol-051116-052133","article-title":"Microbes and cancer.","volume":"35","author":"Dzutsev","year":"2017","journal-title":"Annu Rev Immunol"},{"key":"R79-20250904","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/nature14395","article-title":"Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy.","volume":"521","author":"Shalapour","year":"2015","journal-title":"Nature"},{"key":"R80-20250904","doi-asserted-by":"crossref","first-page":"100744","DOI":"10.1016\/j.xcrm.2022.100744","article-title":"Balance between immunoregulatory B cells and plasma cells drives pancreatic tumor immunity.","volume":"3","author":"Mirlekar","year":"2022","journal-title":"Cell Rep Med"},{"key":"R81-20250904","doi-asserted-by":"crossref","first-page":"101479","DOI":"10.1016\/j.smim.2021.101479","article-title":"The neglected brothers come of age: B cells and cancer.","volume":"52","author":"Shalapour","year":"2021","journal-title":"Semin Immunol"},{"key":"R82-20250904","doi-asserted-by":"crossref","first-page":"5932","DOI":"10.1038\/onc.2008.267","article-title":"NK cells and cancer immunosurveillance.","volume":"27","author":"Waldhauer","year":"2008","journal-title":"Oncogene"},{"key":"R83-20250904","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41577-018-0061-z","article-title":"Natural killer cells and other innate lymphoid cells in cancer.","volume":"18","author":"Chiossone","year":"2018","journal-title":"Nat Rev Immunol"},{"key":"R84-20250904","doi-asserted-by":"crossref","first-page":"102923","DOI":"10.1016\/j.redox.2023.102923","article-title":"Cancer-associated fibroblasts impair the cytotoxic function of NK cells in gastric cancer by inducing ferroptosis via iron regulation.","volume":"67","author":"Yao","year":"2023","journal-title":"Redox Biol"},{"key":"R85-20250904","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2020.00167","article-title":"NK cell-based immune checkpoint inhibition.","volume":"11","author":"Khan","year":"2020","journal-title":"Front Immunol"},{"key":"R86-20250904","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.immuni.2007.03.014","article-title":"T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation.","volume":"26","author":"Li","year":"2007","journal-title":"Immunity"},{"key":"R87-20250904","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lungcan.2005.11.016","article-title":"Polymorphisms in TGF-beta1 gene and the risk of lung cancer.","volume":"52","author":"Kang","year":"2006","journal-title":"Lung Cancer"},{"key":"R88-20250904","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.yexcr.2015.06.007","article-title":"Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.","volume":"336","author":"Yue","year":"2015","journal-title":"Exp Cell Res"},{"key":"R89-20250904","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1038\/s41523-022-00446-6","article-title":"TGFBR1*6A as a modifier of breast cancer risk and progression: advances and future prospects.","volume":"8","author":"Agyemang","year":"2022","journal-title":"NPJ Breast Cancer"},{"key":"R90-20250904","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1165\/ajrcmb.25.5.4539","article-title":"Histone deacetylase inhibitor downregulation of bcl-xl gene expression leads to apoptotic cell death in mesothelioma.","volume":"25","author":"Cao","year":"2001","journal-title":"Am J Respir Cell Mol Biol"},{"key":"R91-20250904","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/JTO.0b013e318194f991","article-title":"A histone deacetylase inhibitor LBH589 downregulates XIAP in mesothelioma cell lines which is likely responsible for increased apoptosis with TRAIL.","volume":"4","author":"Symanowski","year":"2009","journal-title":"J Thorac Oncol"},{"key":"R92-20250904","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S1470-2045(15)70056-2","article-title":"Vorinostat in patients with advanced malignant pleural mesothelioma who have progressed on previous chemotherapy (VANTAGE-014): a phase 3, double-blind, randomised, placebo-controlled trial.","volume":"16","author":"Krug","year":"2015","journal-title":"Lancet Oncol"},{"issue":"4 Suppl 15","key":"R93-20250904","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0093-7754(01)90148-4","article-title":"Preclinical mechanisms of action of docetaxel and docetaxel combinations in prostate cancer.","volume":"28","author":"Pienta","year":"2001","journal-title":"Semin Oncol"},{"key":"R94-20250904","first-page":"3441","article-title":"Docetaxel plus gemcitabine as first-line treatment in malignant pleural mesothelioma: a single institution phase II study.","volume":"29","author":"Ralli","year":"2009","journal-title":"Anticancer Res"},{"key":"R95-20250904","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/COC.0b013e3181cae90e","article-title":"Phase II study of gemcitabine plus docetaxel as second-line treatment in malignant pleural mesothelioma: a single institution study.","volume":"34","author":"Tourkantonis","year":"2011","journal-title":"Am J Clin Oncol"},{"key":"R96-20250904","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1593\/neo.101156","article-title":"Targeted inhibition of multiple receptor tyrosine kinases in mesothelioma.","volume":"13","author":"Ou","year":"2011","journal-title":"Neoplasia"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042245","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T12:05:24Z","timestamp":1756987524000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042245"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,25]]},"references-count":96,"journal-issue":{"issue":"17","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042245","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,25]]}}}